시장보고서
상품코드
1304308

일렉트로컴피턴트 세포 시장 : 용도별, 세포 유형별, 형질전환 효율별, 포장 형태별, 최종사용자별, 지역별 - 시장 규모, 점유율, 전망, 기회 분석(2023-2030년)

Electrocompetent Cells Market,By Application, By Cell Type, By Transformation Efficiency, By Packaging Format, By End-User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

일렉트로컴피턴트 세포는 전기 형질 전환 과정을 통해 외래 DNA를 받아들이고 도입할 수 있는 박테리아 균주입니다. 일반적으로 이 세포는 대규모 세척과 원심분리, 빙하에서 세포를 유지하는 등 시간과 노력이 많이 소요되는 방법으로 제조됩니다. 또한 기존의 절차는 형질전환 효율이 낮기 때문에 이 기술을 사용하여 고품질 클론을 만드는 것은 어렵습니다.

시장 역학 :

분자 복제 연구에 대한 연구 활동과 자금 지원 활동이 증가하고 있습니다. 컴피턴트 세포는 다양한 생명공학 절차에서 높은 효과를 발휘하기 때문에 컴피턴트 세포에 대한 수요가 증가할 것으로 예상됩니다. 이러한 요인은 예측 기간 중 세계 일렉트로컴피턴트 세포 시장의 성장을 지원할 것으로 예상됩니다.

그러나 확실한 기술 지식을 갖춘 숙련된 전문가의 필요성은 예측 기간 중 세계 일렉트로컴피턴트 세포 시장의 성장을 저해할 것으로 예상되는 주요 요인 중 하나입니다.

이 조사의 주요 특징

  • 이 보고서는 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 CAGR을 제시하는 세계 일렉트로컴피턴트 세포 시장을 상세하게 분석합니다.
  • 또한 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 주요 인사이트도 제공합니다.
  • 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등 다음과 같은 매개 변수를 기반으로 세계 일렉트로컴피턴트 세포 시장의 주요 기업을 프로파일링합니다.
  • 이번 조사 대상 주요 기업에는 Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH(Meridian Bioscience), and Cell Applications, Inc.가 포함됩니다.
  • 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
  • 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자는 세계 일렉트로컴피턴트 세포 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 개요

  • 리포트 개요
    • 시장의 정의와 범위
  • 주요 요약
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 촉진요인
  • 분자 클로닝 연구에서 조사 활동과 자금 제공의 증가
  • 유전자 치료에 대한 투자의 증가
    • 억제요인
  • 숙련 전문가의 부족
    • 기회
  • 재조합 DNA 기술의 진보
  • 영향 분석
  • 주요 하이라이트
  • 규제 시나리오
  • 제품 출시/승인
  • PEST 분석
  • Porter의 산업 분석
  • 합병·인수 시나리오

제4장 세계의 일렉트로컴피턴트 세포 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

  • COVID-19의 역학
  • 공급측과 수요측 분석
  • 경제적 영향

제5장 세계의 일렉트로컴피턴트 세포 시장, 용도별, 2023-2030년

  • 클로닝
  • 단백질 발현
  • 돌연변이유발
  • 게놈 DNA 라이브러리 구축
  • 항체 생산
  • 하이스루풋(High throughput) 스크리닝
  • 기타

제6장 세계의 일렉트로컴피턴트 세포 시장, 세포 유형별, 2023-2030년

  • 대장균(E. coli)
  • Saccharomyces cerevisiae(S. cerevisiae)
  • 고초균(B. subtilis)
  • Pseudomonas putida(P. putida)
  • 폐렴구균(S. pneumoniae)
  • 기타

제7장 세계의 일렉트로컴피턴트 세포 시장, 형질전환 효율별, 2023-2030년

  • 고효율 세포
  • 초고효율 세포

제8장 세계의 일렉트로컴피턴트 세포 시장 : 포장 형태별, 2023-2030년

  • 튜브
  • 플레이트
  • 커스텀 포맷

제9장 세계의 일렉트로컴피턴트 세포 시장 : 최종사용자별, 2023-2030년

  • 제약·바이오테크놀러지 기업
  • 학술·연구기관
  • 임상시험수탁기관(CRO)
  • 기타

제10장 세계의 일렉트로컴피턴트 세포 시장, 지역별, 2023-2030년

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제11장 경쟁 구도

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs, Inc.
  • GenScript Biotech Corporation
  • Lucigen Corporation
  • Takara Bio Inc.
  • Delphi Genetics S.A.

제12장 섹션

  • 조사 방법
  • 출판사 소개
KSA 23.08.11

Electrocompetent cells are bacterial strains that are capable of receiving and transferring foreign DNA by the process of electrotransformation. They are typically prepared by a time-consuming and labor-intensive method that involves extensive washing and centrifugation, as well as maintaining the cells at an ice-cold temperature. The traditional procedure also results in a low transformation efficiency, making it difficult to generate high quality clones using this technique.

Market Dynamics:

There is a rise in research activities and funding activities in molecular cloning studies. This in turn is expected to boost the demand for competent cells as they are highly efficacious in various biotechnology procedures. This factor is expected to support growth of the global electrocompetent cells market over the forecast period.

However, the need for skilled professionals having sound technical knowledge is one of the major factors expected to hamper growth of the global electrocompetent cells market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global electrocompetent cells market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global electrocompetent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), and Cell Applications, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global electrocompetent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocompetent cells market

Detailed Segmentation:

  • Global Electrocompetent Cells Market, By Application:
    • Cloning
    • Protein Expression
    • Mutagenesis
    • Genomic DNA Library Construction
    • Antibody Production
    • High-Throughput Screening
    • Others
  • Global Electrocompetent Cells Market, By Cell Type
    • Escherichia coli (E. coli)
    • Saccharomyces cerevisiae (S. cerevisiae)
    • Bacillus subtilis (B. subtilis)
    • Pseudomonas putida (P. putida)
    • Streptococcus pneumoniae (S. pneumoniae)
    • Others
  • Global Electrocompetent Cells Market, By Transformation Efficiency:
    • High Efficiency Cells
    • Ultra-High Efficiency Cells
  • Global Electrocompetent Cells Market, By Packaging Format:
    • Tubes
    • Plates
    • Custom Formats
  • Global Electrocompetent Cells Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Contract Research Organizations (CROs)
    • Others
  • Global Electrocompetent Cells Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • QIAGEN N.V.
    • Bio-Rad Laboratories, Inc.
    • New England Biolabs, Inc.
    • GenScript Biotech Corporation
    • Lucigen Corporation
    • Takara Bio Inc.
    • Delphi Genetics S.A.
    • IBA GmbH
    • Scarab Genomics LLC
    • Zymo Research Corporation
    • Bioline GmbH (Meridian Bioscience)
    • Cell Applications, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Cell Type
    • Market Snapshot, By Transformation Efficiency
    • Market Snapshot, By Packaging Format
    • Market Snapshot, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rise in research activities and funding activities in molecular cloning studies
  • Increasing investments in gene therapy
    • Restraints
  • Lack of skilled professionals
    • Opportunities
  • Advancements in recombinant DNA technology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Electrocompetent Cells Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Electrocompetent Cells Market , By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Cloning
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Protein Expression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Mutagenesis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Genomic DNA Library Construction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Antibody Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • High-Throughput Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Electrocompetent Cells Market , By Cell Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Escherichia coli (E. coli)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Saccharomyces cerevisiae (S. cerevisiae)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Bacillus subtilis (B. subtilis)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Pseudomonas putida (P. putida)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Streptococcus pneumoniae (S. pneumoniae)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

7. Global Electrocompetent Cells Market , By Transformation Efficiency, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • High Efficiency Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Ultra-High Efficiency Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Global Electrocompetent Cells Market , By Packaging Format, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Tubes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Plates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Custom Formats
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Global Electrocompetent Cells Market , By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

10. Global Electrocompetent Cells Market , By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)

11. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
  • Agilent
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs, Inc.
  • GenScript Biotech Corporation
  • Lucigen Corporation
  • Takara Bio Inc.
  • Delphi Genetics S.A.
  • Analyst Views

12. Section

  • Research Methodology
  • About us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제